RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
@IlindelatorreMD
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @YaseenarabiYa: Online first: our paper in The Lancet Respiratory Medicine by #ACCTG: Intensive care management of coronavirus disease…
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @santiUCI: La mayoría de fármacos vs Covid-19 están en investigación, estudios de fase I, in vitro, o tienen pobre evidencia... La vacun…
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @santiUCI: La mayoría de fármacos vs Covid-19 están en investigación, estudios de fase I, in vitro, o tienen pobre evidencia... La vacun…
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
La mayoría de fármacos vs Covid-19 están en investigación, estudios de fase I, in vitro, o tienen pobre evidencia... La vacuna sigue siendo el jabón #CápsulasdeMedicinaCrítica https://t.co/4elC8sD0nr https://t.co/rIFIXXb5tB
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations https://t.co/lsMzbCw15S
RT @SISIACOficial: Manejo en Cuidados Intensivos de pacientes con #COVID19 publicado por @TheLancet ... Lectura recomendada!!! Link: https…
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations | NEW The Lancet Respiratory Medicine https://t.co/texohaTC6Q
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
RT @AmbrizMau: Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI:…
Evidencia sobre la seguridad y beneficios potenciales de las terapias contra COVID-19: Lancet Respir Med 2020 April 6; DOI: https://t.co/XaTMjnUinF https://t.co/DbLBpogOds
RT @YaseenarabiYa: Online first: our paper in The Lancet Respiratory Medicine by #ACCTG: Intensive care management of coronavirus disease…
RT @biohussein: دراسة تقييمية Review منشورة في مجلة اللانسيت العريقة .. تناقش كيفية التعامل مع مرضى COVID-19 في وحدات العناية المركزة ICU .…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @GermHunterMD: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations Useful algorithms for…
Manejo de cuidados intensivos de la enfermedad por #COVID19: desafíos y recomendaciones. Revisión. @TheLancet https://t.co/gUVpQPYv4a
RT @jocherojas: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations https://t.co/Iu41RFuPj0
RT @YaseenarabiYa: Online first: our paper in The Lancet Respiratory Medicine by #ACCTG: Intensive care management of coronavirus disease…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @SISIACOficial: Manejo en Cuidados Intensivos de pacientes con #COVID19 publicado por @TheLancet ... Lectura recomendada!!! Link: https…
RT @kevindrooney: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations https://t.co/xruH4xxDL4
RT @biohussein: دراسة تقييمية Review منشورة في مجلة اللانسيت العريقة .. تناقش كيفية التعامل مع مرضى COVID-19 في وحدات العناية المركزة ICU .…
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations https://t.co/xruH4xxDL4
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @YaseenarabiYa: Online first: our paper in The Lancet Respiratory Medicine by #ACCTG: Intensive care management of coronavirus disease…
RT @Saludteca: #AyudaBiblioteca En UCI ¿Se deben administrar bloqueadores de citoquinas para prevenir la neumonía o la descompensación? ht…
RT @YaseenarabiYa: Online first: our paper in The Lancet Respiratory Medicine by #ACCTG: Intensive care management of coronavirus disease…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @TxID_Edu: Intensive care management of coronavirus disease 2019 (#COVID19): challenges and recommendations What does everyone think?…
RT @YaseenarabiYa: Online first: our paper in The Lancet Respiratory Medicine by #ACCTG: Intensive care management of coronavirus disease…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @YaseenarabiYa: Online first: our paper in The Lancet Respiratory Medicine by #ACCTG: Intensive care management of coronavirus disease…
RT @GermHunterMD: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations Useful algorithms for…
RT @YaseenarabiYa: Online first: our paper in The Lancet Respiratory Medicine by #ACCTG: Intensive care management of coronavirus disease…
RT @YaseenarabiYa: Online first: our paper in The Lancet Respiratory Medicine by #ACCTG: Intensive care management of coronavirus disease…
Online first: our paper in The Lancet Respiratory Medicine by #ACCTG: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations Abstract in different languages https://t.co/pFTVAqHkD0 #COVID19 #Covid_19 @AcuteCa
RT @DrYaghoobzadeh: Tour de Force @TheLancet @TheLancetInfDis A-Z review! https://t.co/8W0ExDqwHE
RT @Sgf98: "Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations." https://t.co/6g4J3z2KAQ Som…
RT @LancetRespirMed: “Preparations must focus...on staff, including protection from nosocomial transmission and promotion of mental wellbei…
RT @Sgf98: "Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations." https://t.co/6g4J3z2KAQ Som…
RT @biohussein: دراسة تقييمية Review منشورة في مجلة اللانسيت العريقة .. تناقش كيفية التعامل مع مرضى COVID-19 في وحدات العناية المركزة ICU .…
RT @GermHunterMD: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations Useful algorithms for…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
RT @GermHunterMD: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations Useful algorithms for…
RT @LancetRespirMed: “Preparations must focus...on staff, including protection from nosocomial transmission and promotion of mental wellbei…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @LancetRespirMed: Understanding pathways to death in patients with #COVID19 Comment from Jean-Louis Vincent & Fabio S Taccone https://t…
RT @GermHunterMD: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations Useful algorithms for…
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @GermHunterMD: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations Useful algorithms for…
RT @LancetRespirMed: “No proven therapy for #COVID19 exists, but several candidates…have been used empirically and are undergoing investiga…
RT @GermHunterMD: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations Useful algorithms for…
RT @LancetRespirMed: “Current recommendations are based on existing evidence from other viral respiratory infections and general #intensive…
RT @LancetRespirMed: “Preparations must focus...on staff, including protection from nosocomial transmission and promotion of mental wellbei…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @GermHunterMD: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations Useful algorithms for…
RT @MedCritica_: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. https://t.co/aUTbedM6LW
RT @Invesdoctor: Lancet Respiratory Medicineに、COVID-19の集中治療についての総説がありました。「その場で最も熟練したものがフルPPEで挿管する」というのが印象的でした。 Intensive care management o…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations https://t.co/Iu41RFuPj0
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations https://t.co/hd9yMTNIdx
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…